TrialCancer immunology, immunotherapy : CII2011

CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.

Jianda Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.